National Insurance Company (NIC), currently facing a substantial solvency shortfall of ₹8,000 crore, is making strategic moves to bridge the gap by identifying several high-value assets for sale. With its solvency margin standing at a concerning -0.49%, far below the regulatory minimum of 1.5%, the company is under pressure to resolve the situation, according to insiders.
Key Assets Identified for Potential Sale
The insurer has pinpointed assets such as its 20% stake in India International Insurance (Singapore), which is valued at approximately $500 million (around ₹4,000 crore), its stake in Agriculture Insurance Company, and a joint venture in Kenya. While NIC has not yet initiated the sale process or sought the necessary approvals, these assets represent a significant portion of the company’s plan to address its solvency deficit.
Regulatory Relief and Hope for Revaluation
Although the Insurance Regulatory and Development Authority of India (IRDAI) has granted NIC some regulatory forbearance, meaning there is no immediate pressure to sell assets, the company remains optimistic. NIC is looking forward to the transition to a risk-based capital (RBC) framework, which is expected to occur within the next few quarters. The RBC framework could provide significant relief by allowing the insurer to revalue its assets.
One source mentioned, “National Insurance needs ₹8,000 crore to bring its solvency margin back to 1.5%.” The company believes that the transition to the RBC framework could unlock an additional ₹6,000 crore in asset value, primarily through fair value changes. Some assets, currently valued at just ₹500 crore, could see a substantial increase in their valuation under the new framework.
Looking Ahead
While NIC has made progress in identifying key assets for sale, the insurer is yet to start the actual liquidation process. However, the company is banking on the upcoming RBC framework to ease its solvency challenges without rushing into asset sales. The future remains uncertain, but NIC is hopeful that with strategic asset sales and regulatory changes, it can return to a healthier financial position.
